DOCS
Overvalued by 2.3% based on the discounted cash flow analysis.
Market cap | $11.13 Billion |
---|---|
Enterprise Value | $11.05 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.78 |
Beta | 1.41 |
Outstanding Shares | 187,161,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 55.15 |
---|---|
PEG | 124.54 |
Price to Sales | 29.68 |
Price to Book Ratio | 11.87 |
Enterprise Value to Revenue | 21.38 |
Enterprise Value to EBIT | 55.29 |
Enterprise Value to Net Income | 63 |
Total Debt to Enterprise | 0.01 |
Debt to Equity | 0.08 |
No data
No data
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinica...